Skip to Main Content

Paper Details

Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy-the MecMeth/NOA-24 trial.
Trials
12
2022
Author NameAffiliation
Ghazaleh TabatabaiUniversity of Tubingen
Martin GlasDivision of Clinical Neurooncology, University Hospital Essen
Erdem G??resirUniversity Hospital Bonn
Hartmut VatterUniversity Hospital Bonn
  • 1 - 4

Datasets

Release 1.2